Immunome Reports Inducement Grants Under Nasdaq Rule
Immunome, Inc. announced that on October 1, 2026, the Compensation Committee of the Company’s Board of Directors approved inducement grants under Nasdaq Listing Rule 5635(c)(4).
Immunome, Inc. announced that on October 1, 2026, the Compensation Committee of the Company’s Board of Directors approved inducement grants under Nasdaq Listing Rule 5635(c)(4).